Skip to main content
Overview
Press Releases
Events & Presentations
Stock Info
Stock Quote
Analyst Coverage
Financials
Annual Reports
SEC Filings
Governance
Governance Documents
Committee Composition
Senior Management
Board of Directors
Resources
Investor FAQs
Investor Email Alerts
Investor/Media Contacts
Event Details
FDA Approval of MYQORZO (aficamten)
December 19, 2025 1:30 PM PT
Webcast
(opens in new window)